Stockhead TV
Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for patient needs across a variety of therapeutic areas including: pain management, mental health, gut health, diabetes, and allergies.
Medlab specialise in solutions that can provide improved bioavailability leading to better outcomes, fewer side effects and improved quality of life through agile innovative research and expertise in both large and small molecule delivery, throughout the entire supply chain process, from concept to the manufactured end product.
KEY PEOPLE

Dr Sean Hall, CEO, Executive Director
Founding member, and CEO of Medlab Clinical LTD.
Co-authored on multiple patents and publications, active within Medicines Australia, Research Australia, A4M, SOMA, and AusBiotech. Invitational speaker at various food, nutritional and pharmaceutical events and consult on therapeutic development and translational research.

Michael Hall, Non Executive Chairman
Previously worked in chartered accountants offices, Michael joined Grace Brothers in their development phase and rose to be Head Office Controller. After approximately 8 years at Grace Brothers Michael left to have a short stint with Norman Ross (Harvey Norman) and then onto a private merchant bank. Michael became ill with cancer and his experience with that disease introduced him to the area of nutrition. Since that time Michael has been a key player in the successful building of various vitamin companies.

Cheryl Maley, Independent Director
Cheryl, has pharmaceutical experience including over 20 years in roles across sales, marketing, business development, commercial excellence, patient access and general management. During her US (Chicago-based for three years) and Asia tenure (Philippines-based for three years), Mrs Maley focused in seeing products through to regulatory approval; and has gained knowledge of the oncology market.

Laurence McAllister, Independent Director
McAllister is currently CEO of McPherson’s Limited. Under his leadership McPherson’s has delivered an impressive turnaround, growing annual sales revenue to $220M. He brings strong experience in consumer marketing and extensive commercial, M&A and business strategy experience. Mr. McAllister was previously Managing Director for Sanofi in Australia & New Zealand, where he successfully led and turned around the company’s consumer healthcare business. During his tenure at Sanofi he also served on the Board of Medicines Australia for two years.

Drew Townsend, Independent Director
Chairman at Quantum Health Group Ltd and also on the board of Medlab Clinical Ltd. and Member of Australian Institute of Co. Directors, Member of The Institute of Chartered Accountants in Australia, Member of The Institute of Internal Auditors (Australia), Member of Governance Institute of Australia Ltd. and Member of Chartered Accountants Australia & New Zealand.
Mr. Townsend previously was Senior Partner at Hall Chadwick.
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: Cannabis lounges in Las Vegas and Cann’s Mildura cannabis facility gets GMP licence
Health & Biotech
Medlab Clinical heads for Nasdaq listing and land of opportunity
Health & Biotech
Study finds Medlab on right track to advance drug delivery for better patient outcomes
Health & Biotech
Medlab teams up with Malaysian consumer health giant to crack open an eager Asian market
News
Market highlights and 5 ASX small caps to watch on Thursday
Health & Biotech
Could Aussie cannabinoid companies help solve a global opioid crisis?
Health & Biotech
Medlab wants to get right up COVID’s nose, as nasal vaccine program gathers steam
Health & Biotech
Check Up: Money managers are still bullish on Healthcare; here’s what they said
Health & Biotech
Why millions of Aussie patients could be lining up for over-the-counter CBD… but not until 2023
Experts
ScoPo’s Powerplays: ASX health stocks back in favour… or is it flavour?
Health & Biotech
Weed Week: US seed bank launches 4/20 day NFT collection and Washington has a cannabis tax holiday
Health & Biotech
Medlab Clinical shares up ~13% after UK trade deal for patented probiotic NRGBiotic
Health & Biotech
Medlab just axed another Q3 and now the Aussie world beater’s ready to deploy its vast global network
Health & Biotech
Medlab Clinical set to export first CBD product into the UK market
Health & Biotech
Medlab Clinical looks to revolutionise drug delivery for better patient outcomes
News
Weed Week: The Super Bowl bans weed ads even though Snoop is the halftime act
Health & Biotech